Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Hepcludex as the first authorized treatment for chronic hepatitis delta virus infection in the United States, giving patients with the …
FDA Clears First Hepatitis Delta Treatment for U.S. Market Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a clinical trial, suggesting significant advancements in treatment for chronic hepatitis B …
Arbutus Biopharma’s Clinical Trial Shows Promise for Hepatitis B Treatment Read More WARMINSTER, PA and OXFORD, United Kingdom — Arbutus Biopharma Corporation and Barinthus Biotherapeutics recently unveiled encouraging preliminary results from their Phase 2a IM-PROVE II clinical trial at the American Association …
Promising New Data from Hepatitis B Trial by Arbutus and Barinthus Read More